Fig. 01 -

Title Slide

Fig. 02 -

Disclosures

Fig. 03 -

Management

Fig. 04 -

EMBARC/BRR

Fig. 05 -

Exacerbation History

Fig. 06 -

Research Registry

Fig. 07 -

Microbiology of Bronchiectasis

Fig. 08 -

Prognostic impact

Fig. 09 -

Control Infection

Fig. 10 -

Chronic P. aeruginosa Infection

Fig. 11 -

ERS Guidelines

Fig. 12 -

ERS Recommendations

Fig. 13 -

Macrolides

Fig. 14 -

Long-term Macrolide

Fig. 15 -

Individual Patient Data

Fig. 16 -

Prediction of Response

Fig. 17 -

Inhaled Antibiotics

Fig. 18 -

Study Design

Fig. 19 -

Effectively Clear Bacteria

Fig. 20 -

Inconsistent Results

Fig. 21 -

Meta-analysis

Fig. 22 -

ERS Treatment Algorithm

Fig. 23 -

Inhaled Steroids

Fig. 24 -

Inhaled Steroids Study

Fig. 25 -

Inflammation in Bronchiectasis

Fig. 26 -

DPP1 Inhibitor

Fig. 27 -

Future of Antibiotics

Fig. 28 -

Summary

Fig. 29 -

Panel Discussion